{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:26:04Z","timestamp":1767651964678,"version":"3.40.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,17]]},"DOI":"10.7759\/cureus.84267","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T09:04:07Z","timestamp":1747472647000},"source":"Crossref","is-referenced-by-count":1,"title":["Rapid Progression of Dermatomyositis in an Elderly Patient With Oropharyngeal and Pulmonary Involvement: A Case Report"],"prefix":"10.7759","author":[{"given":"Emily O","family":"Broad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-015-0008-8","article-title":"Originators and eponyms of dermatomyositis: Ernst Leberecht Wagner (1821-1888) and Heinrich Unverricht (1853-1912) (Article in German)","volume":"75","author":"Keitel W","year":"2016","unstructured":"Keitel W, Wolff HP. Originators and eponyms of dermatomyositis: Ernst Leberecht Wagner (1821-1888) and Heinrich Unverricht (1853-1912) (Article in German). Z Rheumatol. 2016, 75:429-34. 10.1007\/s00393-015-0008-8","journal-title":"Z Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24786","article-title":"Incidence, prevalence, and mortality of dermatomyositis: a population-based cohort study","volume":"75","author":"Kronzer VL","year":"2023","unstructured":"Kronzer VL, Kimbrough BA, Crowson CS, Davis JM 3rd, Holmqvist M, Ernste FC. Incidence, prevalence, and mortality of dermatomyositis: a population-based cohort study. Arthritis Care Res (Hoboken). 2023, 75:348-55. 10.1002\/acr.24786","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac091","article-title":"Differences in sex- and age-associated mortality in patients with anti-MDA5-positive dermatomyositis","volume":"33","author":"He S","year":"2023","unstructured":"He S, Zhou Y, Fan C, Ma J, Chen Y, Wu W, Zhang X. Differences in sex- and age-associated mortality in patients with anti-MDA5-positive dermatomyositis. Mod Rheumatol. 2023, 33:975-81. 10.1093\/mr\/roac091","journal-title":"Mod Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan A","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975, 292:344-7. 10.1056\/NEJM197502132920706","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17536","article-title":"The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of\u00a0existing criteria","volume":"180","author":"Concha JS","year":"2019","unstructured":"Concha JS, Tarazi M, Kushner CJ, Gaffney RG, Werth VP. The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of\u00a0existing criteria. Br J Dermatol. 2019, 180:1001-8. 10.1111\/bjd.17536","journal-title":"Br J Dermatol"},{"key":"ref6","article-title":"Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study","volume":"35","author":"Andr\u00e1s C","year":"2008","unstructured":"Andr\u00e1s C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P, Dank\u00f3 K. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol. 2008, 35:438-44.","journal-title":"J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-3719","article-title":"Environmental triggers of dermatomyositis: a narrative review","volume":"9","author":"Bax CE","year":"2021","unstructured":"Bax CE, Maddukuri S, Ravishankar A, Pappas-Taffer L, Werth VP. Environmental triggers of dermatomyositis: a narrative review. Ann Transl Med. 2021, 9:434. 10.21037\/atm-20-3719","journal-title":"Ann Transl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-eular.4048","article-title":"AB0627 Prognosis and mortality of dermatomyositis and polymyositis patients with malignancy","volume":"1","author":"Yang X","year":"202079","unstructured":"Yang X, Hao Y, Zhang Z. AB0627 Prognosis and mortality of dermatomyositis and polymyositis patients with malignancy. Ann Rheum Dis. 202079, 1:1609. 10.1136\/annrheumdis-2020-eular.4048","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155381","article-title":"Factors associated with interstitial lung disease in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis","volume":"11","author":"Zhang L","year":"2016","unstructured":"Zhang L, Wu G, Gao D, et al.. Factors associated with interstitial lung disease in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis. PLoS One. 2016, 11:e0155381. 10.1371\/journal.pone.0155381","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2117912","article-title":"Trial of intravenous immune globulin in dermatomyositis","volume":"387","author":"Aggarwal R","year":"2022","unstructured":"Aggarwal R, Charles-Schoeman C, Schessl J, et al.. Trial of intravenous immune globulin in dermatomyositis. N Engl J Med. 2022, 387:1264-78. 10.1056\/NEJMoa2117912","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/ar3704","article-title":"Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine","volume":"14","author":"Schiopu E","year":"2012","unstructured":"Schiopu E, Phillips K, MacDonald PM, Crofford LJ, Somers EC. Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine. Arthritis Res Ther. 2012, 14:R22. 10.1186\/ar3704","journal-title":"Arthritis Res Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199905000-00001","article-title":"Influence of age on characteristics of polymyositis and dermatomyositis in adults","volume":"78","author":"Marie I","year":"1999","unstructured":"Marie I, Hatron PY, Levesque H, et al.. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore). 1999, 78:139-47. 10.1097\/00005792-199905000-00001","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and\u00a0frailty","volume":"15","author":"Ferrucci L","year":"2018","unstructured":"Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and\u00a0frailty. Nat Rev Cardiol. 2018, 15:505-22. 10.1038\/s41569-018-0064-2","journal-title":"Nat Rev Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13144055","article-title":"A review of myositis-associated interstitial lung disease","volume":"13","author":"Kannappan R","year":"2024","unstructured":"Kannappan R, Kumar R, Cichelli K, Brent LH. A review of myositis-associated interstitial lung disease. J Clin Med. 2024, 13:4055. 10.3390\/jcm13144055","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2004.02.024","article-title":"Oropharyngeal dysphagia in polymyositis\/dermatomyositis","volume":"107","author":"Ertekin C","year":"2004","unstructured":"Ertekin C, Se\u00e7il Y, Y\u00fcceyar N, Aydo\u011fdu I. Oropharyngeal dysphagia in polymyositis\/dermatomyositis. Clin Neurol Neurosurg. 2004, 107:32-7. 10.1016\/j.clineuro.2004.02.024","journal-title":"Clin Neurol Neurosurg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154746","article-title":"Oropharyngeal dysphagia in dermatomyositis: associations with clinical and laboratory features including autoantibodies","volume":"11","author":"Mugii N","year":"2016","unstructured":"Mugii N, Hasegawa M, Matsushita T, et al.. Oropharyngeal dysphagia in dermatomyositis: associations with clinical and laboratory features including autoantibodies. PLoS One. 2016, 11:e0154746. 10.1371\/journal.pone.0154746","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20325","article-title":"Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients","volume":"62","author":"Marie I","year":"2010","unstructured":"Marie I, Menard JF, Hatron PY, et al.. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res (Hoboken). 2010, 62:1748-55. 10.1002\/acr.20325","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac057","article-title":"The therapeutic efficacy and safety of intravenous immunoglobulin in dermatomyositis and polymyositis: a systematic review and meta-analysis","volume":"33","author":"Xiong A","year":"2023","unstructured":"Xiong A, Qiang Y, Cao Y, et al.. The therapeutic efficacy and safety of intravenous immunoglobulin in dermatomyositis and polymyositis: a systematic review and meta-analysis. Mod Rheumatol. 2023, 33:533-42. 10.1093\/mr\/roac057","journal-title":"Mod Rheumatol"},{"key":"ref19","article-title":"High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels","volume":"10","author":"G\u00f6ttfried I","year":"2000","unstructured":"G\u00f6ttfried I, Seeber A, Anegg B, Rieger A, Stingl G, Volc-Platzer B. High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels. Eur J Dermatol. 2000, 10:29-35.","journal-title":"Eur J Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015578","article-title":"Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis\/dermatomyositis","volume":"98","author":"Temmoku J","year":"2019","unstructured":"Temmoku J, Sato S, Fujita Y, et al.. Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis\/dermatomyositis. Medicine (Baltimore). 2019, 98:e15578. 10.1097\/MD.0000000000015578","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/352811-rapid-progression-of-dermatomyositis-in-an-elderly-patient-with-oropharyngeal-and-pulmonary-involvement-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T09:04:08Z","timestamp":1747472648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/352811-rapid-progression-of-dermatomyositis-in-an-elderly-patient-with-oropharyngeal-and-pulmonary-involvement-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.84267","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,17]]}}}